This MedLibrary.org supplementary page on C. Gordon Zubrod is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Dr Charles Gordon Zubrod (1914-January 19, 1999) was an American oncologist who played a prominent role in the introduction of chemotherapy for cancer. He was one of the recipients of the 1972 Albert Lasker Awards in recognition of his contributions to the field, amongst many other doctorates and awards.
Contents |
Life and work
Dr. Zubrod, an alumnus of the Georgetown Preparatory School (class of 1932) and Columbia University College of Physicians and Surgeons (1940 class), served in the U.S. army medical corps during World War II, where he worked on a replacement for quinine in the treatment of malaria. The unit eventually discovered chloroquine.
In 1946 he commenced work at Johns Hopkins University Medical School, and was appointed assistant professor of medicine and director of research at Saint Louis University in 1953. This position lasted briefly: he became clinical director of the National Institutes of Health in 1954 and became head of the Division of Cancer Treatment of the National Cancer Institute in 1956 and scientific director in 1961. Here, he put an emphasis on the development of new chemotherapy agents and their use in clinical trials. He is credited with the introduction of the platinum-containing compounds (e.g. cisplatin). Several other new classes of chemotherapeutics were identified under Zubrod's leadership.
Dr. Zubrod's name is also connected to a widely used assessment scale for performance of cancer patients, the Performance Status of the Eastern Cooperative Oncology Group (ECOG) for Patients with Cancer (Zubrod scale).
Zubrod left the NCI in 1974, and became a professor and chair of the department of oncology at the University of Miami School of Medicine (now the Leonard M. Miller School of Medicine) and served at the director of the Florida Comprehensive Cancer Center. He retired from this position in 1990.
See also
Biography
- Frei III E. In Memoriam C. Gordon Zubrod MD. J Clin Oncol 1999;17:1331-3.
- A tribute to Dr. Charles Gordon Zubrod: January 22, 1914 - January 19, 1999. Miami, Fla.: University of Miami, 1999.
Books
- Sugarbaker, Everett V; Ketcham, Alfred S; Zubrod, C Gordon. Interdisciplinary cancer therapy : adjuvant therapy. Chicago: Year Book Medical Publishers, 1977.
- Zubrod, C Gordon. Perspectives in cancer. In: Clinical Cancer Seminar (1975: Miami, Fla.). Hormones and Cancer. New York: Stratton Intercontinental Medical Book Corp., 1976.
Review papers
- Zubrod, CG.Historic milestones in curative chemotherapy. Semin Oncol. 1979 Dec;6(4):490-505. PMID 394331
- Zubrod CG, Selawry O. The treatment of lung cancer. Adv Intern Med. 1978;23:451-67. PMID 204171
- Zubrod CG. Present status of cancer chemotherapy. Life Sci. 1974 Mar 1;14(5):809-18. PMID 4597493
- Zubrod CG. Trends in chemotherapy research. Proc Can Cancer Conf. 1969;8:31-9. PMID 4893428
- Zubrod CG. The skin and antitumor drugs. Arch Dermatol. 1967 Nov;96(5):560-4. PMID 4861428
External links
Wikipedia content modification information:
- This page was last modified on 8 October 2008, at 12:11.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "C. Gordon Zubrod".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.